High-priced technology can be good value for money. [Ann Intern Med. 1999]

Cited by 2 PubMed Central articles

Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment.
Siebert U, Sroczynski G, German Hepatitis C Model (GEHMO) Group, HTA Expert Panel on Hepatitis C. Ger Med Sci. 2003 Nov 3; 1:Doc07. Epub 2003 Nov 3.

[Ger Med Sci. 2003]
Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.
Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB, German Hepatitis C Model (GEHMO) Group, et al. Gut. 2003 Mar; 52(3):425-32.

[Gut. 2003]

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.